Electrochemical, Computational, and Photophysical Characterization of New Luminescent Dirhenium–Pyridazine Complexes Containing Bridging OR or SR Anions by Alessio Raimondi (2108038)

“…A series of [Re₂(μ-ER)₂(CO)₆(μ-pydz)] complexes have been synthesized (E = S, R = C₆H₅, <b>2</b>; E = O, R = C₆F₅, <b>3</b>; C₆H₅, <b>4</b>; CH₃, and <b>5</b>; H, <b>6</b>), starting either from [Re­(CO)₅O₃SCF₃] (for <b>2</b> and <b>4</b>), [Re₂(μ-OR)₃(CO)₆]⁻ (for <b>3</b> and <b>5</b>), or [Re₄(μ₃-OH)₄(CO)₁₂] (for <b>6</b>). …”

Supplementary Figure 4 from Decreased eIF3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGFβ Signaling Pathway by Guillaume Desnoyers (232704)

Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation by Christian Berrios (127454)

“…While MYC was required for MCT1 induction, MCPyV-induced MCT1 levels decreased following knockdown of the NF-κB subunit RelA, supporting a synergistic activity between MCPyV and MYC in regulating MCT1 levels. …”

Inflammation-free survival by predicted risk group. by Sanghee Kim (75767)

Supplemental Figure S1 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophag... by Yueying Liu (1635625)

Supplemental Figure S4 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophag... by Yueying Liu (1635625)

Supplemental Figure S3 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophag... by Yueying Liu (1635625)

Supplemental Figure S2 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophag... by Yueying Liu (1635625)

A Family of Binuclear Dysprosium(III) Radical Compounds with Magnetic Relaxation in ON and OFF States by Tian Han (1674109)

“…The adduct ([Dy­(hfac)₃(PyNONIT)]₂[Dy_0.5(hfac)_1.5(H₂O)]₂) (<b>3</b>) consists of two items, the dimer [Dy­(hfac)₃(PyNONIT)]₂ and the monomer [Dy­(hfac)₃(H₂O)₂], where the symmetry of Dy^III ion in Dy₂O₂ decreases to <i>D</i>_2<i>d</i>, showing slow relaxation of the magnetization at lower temperature. …”

Physiological Markers of Arousal Change with Psychological Treatment for Insomnia: A Preliminary Investigation by Christopher B. Miller (838716)

“…</p><p>Results</p><p>Eight (73%) patients out of 11 consented completed therapy and showed a decrease in insomnia severity pre-to-post treatment (mean (SD): 18.1 (2.8) versus 8.4 (4.8); <i>p</i> = .001). …”

Supplementary Material for: MNSFβ Promotes the Proliferation and Migration of Human Extravillous Trophoblast Cells and the Villus Expression Level of MNSFβ Is Decreased in Recurren... by Wang N. (3112722)

Deletion of <i>iscR</i> decreases <i>K. pneumoniae</i> Δ<i>fur</i> siderophore production assessed using CAS assay. by Chien-Chen Wu (281137)

Data Sheet 1_Evaluating the efficacy of different doses of tocilizumab in treating critically ill COVID–19 patients: a single–center retrospective cohort study.docx by Jie Gao (10266)

<i>In planta</i> expression and phenotypic contributions of <i>Ralstonia</i> lectin genes <i>lecF</i> and <i>lecX</i>. A) Expression of lectin genes <i>lecF</i> and <i>lecX</i> was... by Mariama D. Carter (19727487)

Loss of pathogenicity of the <i>abpacc</i> mutant and decreased virulence of Δ<i>abvf8</i> compared to wild-type <i>Alternaria brassicicola</i>. by Yangrae Cho (816)

A fitted regression model that shows the relationship between distillation time (DT) and the concentration (%) of (A) β-caryophyllene, (B) maaliol, (C) germacrene D-4-ol, (D) spath... by Valtcho D. Zheljazkov (627617)

The data of meta-analysis. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Quality assessment for risk of bias for studies. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

The results of safety in meta-analysis. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”